Pursuant to Regulations 30 and 46(2) (oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zydus Lifesciences has informed that it attached the Transcript of the Company’s Q1 FY24 post results earnings call held on August 11, 2023.